Yi Shi Bio is a joint venture and a leading IVD solution provider. With manufacturing facilities in Beijing, Nantong, and Wuxi, Yi Shi Bio develop, produce, and distribute diagnostic kits all over the world. Their products include Rapid Tests, Elisa kits, CLIA and POCT analyzer systems, and they have registered the trade mark EGENS. To date, EGENS has received certification for its quality management systems (QMS) under the following standards: ISO9001, ISO13485 CMDR, ISO14001, OSHAS18001, and GMP.

Anyuan Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese private company located in Shanghai. The firm develops biological macromolecular drugs. It was founded in 2016. Qiang Li is currently the CEO of the company.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Xuhua (Shanghai) Biological R&D Center Co., Ltd., established on 2001-08-08, Business scope includes research,Development of long-acting genetically engineered drugs,Monoclonal Antibodies for Pharmaceutical Use,Technology transfer of self-developed results,And provide relevant technical advice.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Changsha Xinlizhihe Technology Co., Ltd., established on 2020-05-13, Business scope includes medical research and experimental development;research and development,Incubation and Transformation;Electronic equipment,Instrumentation,sensor,scientific model,Testing Equipment,Class I medical device,Class II medical device,Polymer materials and their products,Research and development of industrial automation equipment;Technical services related to polymer materials and their products;Development of medical testing technology;Medical laboratory technical service;Food safety testing products related technical services;Food safety testing reagent related technical services;High-tech research;Medical supplies and equipment retail;Class I medical device,Sales of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Jiangsu Eureka Biotechnology Co., Ltd., established on 2005-10-17, Business scope includes pharmaceutical intermediates(Does not contain dangerous goods)Development,production and sales;Seedling planting and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

UBI Pharma, Inc. engages in the research, development, manufacture and sale of non-antibody protein drugs, small molecule new drugs and special medicine. Its products include Ubixa film coated tablets, levetiracetam concentrate solution, and lamivudine film coated tablets. It also provides commissioned drug manufacturing and technical services. The company was founded by Yi Cheng Wang on July 31, 2014 and is headquartered in Hsinchu, Taiwan.

Using the Principal Investigator's background in epidemiology and clinical ophthalmology, the Zietchick Research Institute is currently seeking new treatments for eye diseases that primarily target mothers and infants.

Part of LivzonBio, Inc., Livzon MABPharm Inc. is a Chinese company located in Zhuhai specializing in pharmaceutical preparations.

Ellume creates, manufactures, and sells the next generation of digitally enabled diagnostic equipment for doctors and patients. Dr. Sean Parsons invented Ellume during the 2009 H1N1 pandemic. As a physician in an emergency department, he was confronted with a dearth of quick, accurate diagnostic tests, which were critical in limiting transmission and enabling early treatment.

Chengdu Aiweifu Biotechnology Co., Ltd., established on 2017-01-25, Business scope includes biotechnology development,technical consulting,Technical Services,technology transfer;software development;Instrumentation,chemical reagent,Polymer Materials,Research and development of active equipment and consumables,Production,Sales;Medical device research and development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).Medical device production,Sales.(Did not obtain the relevant administrative license(approval),Do not carry out business activities).

Shanghai Pudong Mingyan Biotechnology Co., Ltd., established on 2000-10-27, The scope of business includes engaging in technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services,Air conditioner accessories,pipe fittings,Manufacturing of hardware machinery parts,processing. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Ningbo Renjian Pharmaceutical Co., Ltd., founded in 1988, is a high-tech enterprise specialized in manufacturing biochemical drugs, synthetic pharmaceutical intermediates, APIs and preparations. It has a staff of 500, in which technical personnel is more than 130. More than 90% of the products are exported to Europe, America, Japan, Southeast Asia, etc. The company has the honor to receive many awards such as “Top Export Enterprises of Ningbo”, “Technology Advancement Enterprises of Cixi”, “Model Enterprises for Science and Technology Innovation of Cixi”, “High Technology and New Technology enterprises of Cixi”, “High Technology and New Technology enterprises of Zhejiang Province 2002”The company's R&D center is evaluated “Provincial High Technology and New Technology Research and Development Center”. Biochemical APIs and Preparations: The manufacturing site, located at 555 Changchi Road in Cixi, occupies a land area of 40,000 square meters. It started operation in 2004 and passed GMP inspection in the same year. It has a good environment, professional layout and flow, adanced facilities. It produces APIs such as chorionic gonadotropin (hCG), menotropins (hMG), heparin sodium, oxytocin solution, powdered posterior pituitary , etc, and lyophilized powders for injection and small volume injections. Chorionic gonadotropin (hCG), menotropins (hMG) APIs and injections are main products. Chorionic gonadotropin (hCG) were continual twice evaluated “Famous Brand Products of Ningbo” .Lyophilized powder for injections and small volume injections includes Chorionic gonadotropin (hCG) for injection, menotropins (hMG) for injection, co-enzyme A for injection, oxytocin injection and ethylenediamine diaceturate injection, etc.

Furen Medicines Group is engaged in pharmaceutical research and development, manufacturing and marketing generic drugs.

Kaifeng Pharmaceutical (Group) Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include injection, tablets, capsules, granules, eye drops, ointments, and pharmaceutical raw materials. The company was founded on May 17, 1949 and is is headquartered in Kaifeng, China.